Credit Suisse’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-97,328
| Closed | -$389K | – | 4379 |
|
|
2019
Q4 | $389K | Buy |
97,328
+41,264
| +74% | +$194K | ﹤0.01% | 3695 |
|
|
2019
Q3 | $275K | Buy |
56,064
+13,886
| +33% | +$77.7K | ﹤0.01% | 3738 |
|
|
2019
Q2 | $257K | Buy |
42,178
+348
| +0.8% | +$1.85K | ﹤0.01% | 3755 |
|
|
2019
Q1 | $243K | Buy |
41,830
+980
| +2% | +$10.1K | ﹤0.01% | 3699 |
|
|
2018
Q4 | $550K | Buy |
40,850
+8,321
| +26% | +$140K | ﹤0.01% | 3192 |
|
|
2018
Q3 | $631K | Sell |
32,529
-60,027
| -65% | -$1.28M | ﹤0.01% | 3170 |
|
|
2018
Q2 | $2.37M | Sell |
92,556
-6,845
| -7% | -$160K | ﹤0.01% | 2316 |
|
|
2018
Q1 | $2M | Buy |
99,401
+28,220
| +40% | +$658K | ﹤0.01% | 2422 |
|
|
2017
Q4 | $1.43M | Buy |
71,181
+21,335
| +43% | +$420K | ﹤0.01% | 2727 |
|
|
2017
Q3 | $1.03M | Buy |
49,846
+24,887
| +100% | +$421K | ﹤0.01% | 3070 |
|
|
2017
Q2 | $369K | Sell |
24,959
-25,827
| -51% | -$430K | ﹤0.01% | 3356 |
|
|
2017
Q1 | $810K | Sell |
50,786
-27,027
| -35% | -$390K | ﹤0.01% | 3019 |
|
|
2016
Q4 | $980K | Buy |
77,813
+38,237
| +97% | +$712K | ﹤0.01% | 3045 |
|
|
2016
Q3 | $1.11M | Sell |
39,576
-7,220
| -15% | -$242K | ﹤0.01% | 2869 |
|
|
2016
Q2 | $1.64M | Buy |
46,796
+11,507
| +33% | +$362K | ﹤0.01% | 2501 |
|
|
2016
Q1 | $967K | Buy |
35,289
+3,493
| +11% | +$103K | ﹤0.01% | 2753 |
|
|
2015
Q4 | $1.09M | Sell |
31,796
-3,309
| -9% | -$103K | ﹤0.01% | 2750 |
|
|
2015
Q3 | $1.01M | Sell |
35,105
-2,967
| -8% | -$127K | ﹤0.01% | 2816 |
|
|
2015
Q2 | $1.7M | Buy |
38,072
+27,037
| +245% | +$1.02M | ﹤0.01% | 2678 |
|
|
2015
Q1 | $382K | Sell |
11,035
-1,814
| -14% | -$49.4K | ﹤0.01% | 3718 |
|
|
2014
Q4 | $352K | Buy |
+12,849
| New | +$312K | ﹤0.01% | 3952 |
|
Other funds holding DPLO
Credit Suisse's DPLO Position: Q1 2020 in Review
Credit Suisse sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q1 2020, closing a stake of 97,328 shares — an estimated $389K sold.
Credit Suisse first reported a position in DPLO in Q4 2014 and held it in 21 quarters. The position peaked at $2.37M in Q2 2018. 1 fund tracked by Wall St. Rank holds DPLO as of Q1 2020.
- Credit Suisse reported no remaining DIPLOMAT PHARMACY, INC. position as of Q1 2020 after selling out during the quarter.
- Credit Suisse sold 97,328 DIPLOMAT PHARMACY, INC. shares in Q1 2020, an estimated $389K.
- Credit Suisse first reported a position in DIPLOMAT PHARMACY, INC. in Q4 2014 and held it in 21 quarters.
- Credit Suisse's DIPLOMAT PHARMACY, INC. position peaked at $2.37M in Q2 2018.
- 1 fund tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q1 2020.
Based on Credit Suisse's 13F filing for Q1 2020, filed 13 May 2020.